NEW YORK (GenomeWeb News) – Roche NimbleGen said today that it has aligned its chromatin immunoprecipitation-on-microarrays (ChIP-chip) with Sigma Aldrich's GenomePlex whole-genome amplification technology, and the companies will co-market the technologies together.

Researchers can use the two platforms together to study the genome for epigenetic interactions between DNA and DNA-binding proteins to find out what regions are transcriptionally active or repressed, and the mechanisms that regulate these processes, Roche said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.